Folate fluorescein isothiocyanate conjugate - On Target Laboratories

Drug Profile

Folate fluorescein isothiocyanate conjugate - On Target Laboratories

Alternative Names: EC-17; Folate receptor-alpha-targeted fluorescent agent - OnTarget Laboratories; Folate receptor-alpha-targeted imaging agent - OnTarget Laboratories; Folate-5-fluorescein isothiocyanate; Folate-FITC conjugate; Folate-fluorescein isothiocyanate; OTL-0038; OTL-38

Latest Information Update: 13 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Endocyte; Purdue University
  • Developer Centre for Human Drug Research; Indiana University School of Medicine; Leiden University Medical Center; On Target Laboratories; Purdue University; University of Pennsylvania
  • Class Cancer vaccines; Fluoresceins; Haptens; Imaging agents
  • Mechanism of Action Diagnostic imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Lung cancer; Ovarian cancer
  • Phase I Breast cancer; Pituitary cancer; Primary hyperparathyroidism; Renal cell carcinoma

Most Recent Events

  • 12 Jun 2017 On Target Laboratories plans a phase III trial for Ovarian cancer (Diagnosis) (NCT03180307)
  • 04 May 2017 Phase-II clinical trials in Lung cancer (Diagnosis) in USA (IV) (NCT02872701)
  • 05 Aug 2016 On Target Laboratories plans a phase II trial for Lung cancer (Diagnosis) in USA (NCT02872701)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top